Independent report

Child-family screening for familial hypercholesterolemia: ethical issues

An analysis of the ethical issues raised by child-family cascade screening for familial hypercholesterolemia (FH).

Documents

Details

In 2020, the UK National Screening Committee (UK NSC) set up an ethics task group to carry out an analysis of the ethical issues raised by child-family cascade screening for familial hypercholesterolemia (FH). The group included members with expertise in ethics, paediatrics, clinical genetics, sociology, primary care and public health and a patient representative.

Updates to this page

Published 10 February 2022

Sign up for emails or print this page